A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment

Venous thromboembolism (VTE) is a common and serious complication in patients with cancer; treatment guidelines recommend extended therapy of ≥6 months with low-molecular-weight heparin (LMWH) for treatment and prevention of recurrent VTE (rVTE) in this population. This post hoc analysis used data f...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodruff, Seth, Feugère, Guillaume, Abreu, Paula, Heissler, Joseph, Ruiz, Marcia T., Jen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040733/
https://www.ncbi.nlm.nih.gov/pubmed/27344439
http://dx.doi.org/10.1007/s11239-016-1386-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040733/
https://www.ncbi.nlm.nih.gov/pubmed/27344439
http://dx.doi.org/10.1007/s11239-016-1386-8

Ejemplares similares